Investigation of the effects of BTS 67 5
β
M.J. Cooling; P. Spencer; D. Yates; M.F. Sim; R.B. Jones
π
Article
π
1999
π
John Wiley and Sons
π
English
β 167 KB
BTS 67 582 stimulates insulin release and causes dose-dependent glucose-lowering activity in the conscious beagle dog. Plasma glucose levels were lowered within 1 h and were maximally reduced by 53.2 Β± 2.7% 2-3 h after oral dosing with 90 Β΅mol/kg BTS 67 582 (equivalent to 22.5 mg/kg as the free base